CG
MGNX icon

Cutler Group’s MacroGenics MGNX Stock Holding History

Cutler Group’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,000
Closed -$6K – 4409
2019
Q4 		$6K Hold
1,000
– – ﹤0.01% 2942
2019
Q3 		$5K Hold
1,000
– – ﹤0.01% 3034
2019
Q2 		$3K Buy
+1,000
New +$17.2K ﹤0.01% 3397
2017
Q2 		– Sell
-1,000
Closed -$2K – 6777
2017
Q1 		$2K Hold
1,000
– – ﹤0.01% 5481
2016
Q4 		$3K Buy
+1,000
New +$25.2K ﹤0.01% 5340
2016
Q2 		– Sell
-8,000
Closed -$94K – 7024
2016
Q1 		$94K Buy
8,000
+5,100
+176% +$97.1K 0.01% 1676
2015
Q4 		$4K Buy
+2,900
New +$88.1K ﹤0.01% 5083

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Cutler Group's MGNX Position: Q4 2021 in Review

Cutler Group sold out of MacroGenics (MGNX) in Q4 2021, closing a stake of 756 shares — an estimated $15K sold.

Cutler Group first reported a position in MGNX in Q4 2015 and held it in 12 quarters. The position peaked at $127K in Q1 2016. 156 funds tracked by Wall St. Rank hold MGNX as of Q4 2021.

  • Cutler Group reported no remaining MacroGenics position as of Q4 2021 after selling out during the quarter.
  • Cutler Group sold 756 MacroGenics shares in Q4 2021, an estimated $15K.
  • Cutler Group first reported a position in MacroGenics in Q4 2015 and held it in 12 quarters.
  • Cutler Group's MacroGenics position peaked at $127K in Q1 2016.
  • 156 funds tracked by Wall St. Rank held MacroGenics as of Q4 2021.

Based on Cutler Group's 13F filing for Q4 2021, filed 18 Jan 2022.